NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model

Nephrology Dialysis Transplantation

Volumn 22, Issue 2, 2007, Pages 376-385

  Khanna, Ashwani K ^a,b   Pieper, Galen M ^c,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b OncoDetect Inc   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

Anti TGF antibody; NADPH oxidase; Nephrotoxicity; Rat renal transplant model; Tacrolimus; TGF

Indexed keywords

CREATININE; IMMUNOGLOBULIN G1 ANTIBODY; MESSENGER RNA; NITROGEN; PROTEIN P22; PROTEIN SUBUNIT; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TACROLIMUS; THIOREDOXIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MODEL; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; LEWIS RAT; LOW DRUG DOSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ANALYSIS; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; WISTAR FURTH RAT;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROGNOSIS; RAC1 GTP-BINDING PROTEIN; RATS; RATS, INBRED LEW; RATS, INBRED WF; RNA, MESSENGER; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846663966     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl608     Document Type: Article

References (39)

1. Khanna AK, Hosenpud JS, Plummer MS, Hosenpud JD. Analysis of TGF-β and pro-fibrogenic molecules in a rat cardiac allograft model treated with cyclosporine. Transplantation 2000; 73: 1543-1549
2. Khanna AK, Plummer M, Bromberek C et al. Expression of TGF-β and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int 2002; 62: 2257-2263
3. Khanna AK. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. Transplantation 2000; 70: 690-694
4. Khanna A, Cairns V, Hosenpud JD. Tacrolimus induces increased expression of transforming growth factor-beta in lymphoid and non-lymphoid cells. Transplantation 1999; 67: 614-619
5. Khanna A, Cairns V, Becker CG, Hosenpud JD. Transforming growth factor-β (TGF-β) mimics and anti-TGF-β antibody abrogates the in-vivo effects of cyclosporine: Demonstration of a direct role of TGF- in immunosuppression and nephrotoxicity of CsA. Transplantation 1999; 67: 882-889
6. Campistol JM, Inigo P, Larios S et al. Role of transforming growth factor-beta(1) in the progression of chronic allograft nephropathy. Nephrol Dial Transplant 2001; 1 [16 Suppl]: 114
7. Khanna AK, Plummer MS, Hilton G et al. Anti-transforming growth factor-antibody at low, but not high doses, limits CsA-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications. Circulation 2004; 110: 3822-3829
8. Vural A, Yilmaz MI, Çaǧlar K et al. Assessment of oxidative stress in the early posttransplant period: Comparison of cyclosporine A and tacrolimus-based regimens. Am J Nephrol 2005; 25: 250-255
9. Anjaneyulu M, Tirkey N, Chopra K. Attenuation of cyclosporine-induced renal dysfunction by catechin: Possible antioxidant mechanism. Ren Fail 2003; 25: 691-707
10. Herrara B, Murillo MM, Álvarez-Barrientos A et al. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-β in fetal rat hepatocytes. Free Radical Biol Med 2004; 36: 16-26
11. Sato M, Kawai-Kowase K, Sato H et al. c-Src and hydrogen peroxide mediate transforming growth factor-β1-induced smooth muscle cell-gene expression in 10T1/2 cells. Arterioscler Thromb Vasc Biol 2005; 25: 341-347
12. Sharma K, Cook A, Smith M et al. TGF-β1 impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 2005; 288: F1069-F1077
13. Rhyu DY, Yang Y, Ha H et al. Role of reactive oxygen species in TGF-1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005; 16: 667-675
14. Bokoch GM, Knaus UG. NADPH oxidases: Not just for leukocytes anymore! Trends Biochem Sci 2003; 28: 502-508
15. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003; 24: 471-47
16. Geiszt M, Leto TL. The Nox family of NAD(P)H oxidases: Host defense and beyond. J Biol Chem 2004; 279: 51715-718
17. Krause KH. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn J Infect Dis 2004; 57: S28-S29
18. Chabrashvili T, Kitiyakara C, Blau J et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Renal Integr Comp Physiol 2003; 285: R117-R
19. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725-1738
20. Randhawa PS, Shapiro R, Jordan ML et al. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK-506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol 1993; 17: 60-68
21. Stillman IE, Andoh TF, Burdmann EA et al. FK-506 nephrotoxicity: morphologic and physiologic characterization of a rat model. Lab Invest 1995; 73: 794-803
22. Shihab FS, Bennett WM, Tanner AM, Andoh TF. Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. Transplantation 1997; 64: 1829-1837
23. Plosker GL, Foster RH. Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 2000; 59: 323-389
24. Khanna AK. Tacrolimus and cyclosporine in vitro and in vivo induce osteopontin mRNA expression in renal tissues. Nephron Exp Nephrol 2005; 101: 119-126
25. Vetter M, Chen ZJ, Chang GD et al. Cyclosporin A disrupts bradykinin signaling through superoxide. Hypertension 2003; 41: 1136-1142
26. Zhou X, Yang G, Davis CA et al. Hydrogen peroxide mediates FK506-induced cytotoxicity in renal cells. Kidney Int 2004; 65: 139-147
27. Simmons EM, Langone A, Sezer MT et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 2005; 79: 914-919
28. Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 1996; 10: 1077-1083
29. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E. Kidney Int 1995; 47: 927-934
30. Ahmed SS, Strobel HW, Napoli KL, Grevel J. Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes. J Pharmacol Exp Ther 1993; 265: 1047-1054
31. Ahmed SS, Napoli KL, Strobel HW. Oxygen radical formation during cytochrome P450-catalyzed cyclosporine metabolism in rat and human liver microsomes at varying hydrogen ion concentrations. Mol Cell Biochem 1995; 151: 131-140
32. Serino F, Grevel J, Napoli KL et al. Oxygen radical formation by the cytochrome P450 system as a cellular mechanism for cyclosporine toxicity. Transplant Proc 1994; 26: 2916-2917
33. Yamada K, Sugisaki Y, Suzuki S et al. New morphological changes induced by FK506 in a short period in the rat kidney and the effect of superoxide dismutase and OKY-046 on THEM: The relationship of FK506 nephrotoxicity to lipid peroxidation and change in production of thromboxane A2 in the kidney. Transplant Int 1992; 5: S564-S567
34. Bellocq A, Azoulay E, Marullo S et al. Reactive oxygen and nitrogen intermediates increase transforming growth factor-betal release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 1999; 21: 128-136
35. Sharma R, Khanna AK, Sharma M, Savin V. TGF- increases albumin permeability of isolated rat glomeruli via hydroxyl radical. Kidney Int 2000; 58: 131-136
36. Hisaki R, Fujita H, Saito F, Kushiro T. Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats. Am J Hypertens 2005; 18: 707-713
37. Zhang JJ, Bledsoe G, Kato K et al. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney Int 2004; 66: 722-732
38. Saito K, Ishizaka N, Aizawa T et al. Role of aberrant iron homeostasis in the upregulation of transforming growth factor-betal in the kidney of angiotensin II-induced hypertensive rats. Hypertens Res 2004; 27: 599-607
39. Fujii S, Zhang L, Igarashi J, Kosaka H. L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension. 2003; 42: 1014-1020